RTP, N.C. (April 12, 2011) — BioResource International, Inc. (www.briworldwide.com), a North Carolina-based agricultural biotechnology company, announces today the signing of a formal agreement to construct a manufacturing facility in China. BRI has partnered with Taiwan-based Yung Zip Chemical Industrial Co., Ltd. and Yung Shin Pharmaceutical Co., Ltd. to purchase the land and begin construction in Tianmen, a city in Hubei Province, China. The plant will be used to produce BRI’s patented natural feed additives that improve chicken and pig nutrition, thereby lowering costs and reducing waste associated with farming operations.
The decision is a result of the growth in global demand for products such as BRI's Versazyme® and Valkerase.® The global feed additives market is expected to reach $18 billion by 2015, according to a 2010 report by Global Industry Analysts, Inc.
“We are excited to work with our partners and the government of Tianmen,” says Giles Shih, Ph.D., BRI president and CEO. “This project is a great fit with our three-fold strategic plan of investing in strong global partnerships, environmental sustainability and long-term profitable growth."
The construction and operations of the China manufacturing facility will support economic development for the region and provide immediate economic and environmental benefits for the rapidly growing poultry and swine industry in greater Asia. Moreover, the strategic location in China will allow BRI to be closer to Asian consumers, thereby reducing the carbon footprint and the shipping time involved in delivering products.
Construction is scheduled to begin this summer and the new facility will be operational by the end of 2012. Once complete, the new facility will serve the needs of mainland China, while BRI’s U.S. facility in Apex, North Carolina will focus on filling orders across the Americas, Southeast Asia and the Middle East. BRI’s RTP headquarters will continue to be the center for new product development and innovation.
About BioResource International, Inc.:
BRI is an RTP-based biotechnology company focused on harnessing the natural power of enzymes. Through the discovery and development of innovative animal feed enzymes, BRI hopes to create a future for animal agriculture that is both economically and environmentally sustainable from farm to fork. Founded by Drs. Jason and Giles Shih, BRI has developed two products, Versazyme® and Valkerase®, which are distributed to more than 80 countries worldwide. BRI continues to research science-based solutions to aid growing agricultural and industrial markets around the world. For more information, visit www.briworldwide.com.